Skip to main content
. Author manuscript; available in PMC: 2014 Dec 17.
Published in final edited form as: Cochrane Database Syst Rev. 2013 Dec 3;12:CD005431. doi: 10.1002/14651858.CD005431.pub3
Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Short-term visual acuity from 20/20 to 20/40 3 303 Odds Ratio (M-H, Fixed, 95% CI) 1.65 [0.91, 2.99]
2 Time to resolution of primary hemorrhage (days) Other data No numeric data
3 Risk of secondary hemorrhage 5 578 Odds Ratio (M-H, Fixed, 95% CI) 0.25 [0.13, 0.49]
4 Time to rebleed (days) Other data No numeric data
5 Risk of corneal blood stain 2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
6 Risk of glaucoma or elevated intraocular pressure (IOP) 4 543 Odds Ratio (M-H, Fixed, 95% CI) 1.23 [0.70, 2.16]
7 Risk of optic atrophy 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
8 Adverse effects: nausea or vomiting 2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
9 Duration of hospitalization (days) Other data No numeric data